Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

Investment analysts at Leerink Partnrs dropped their Q3 2025 EPS estimates for shares of Elevance Health in a research note ...

Avior Wealth Management LLC boosted its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...

Fifth Third Bancorp cut its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 26.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The ...

Elevance Health reported stronger-than-expected results and raised its dividend as it benefited from higher premiums, ...

Shares of Elevance Health were gaining after the health insurer turned in a strong quarter and increased its quarterly ...

Elevance Health released fourth-quarter earnings that topped analyst expectations, sending its stock higher in pre-market ...

Medicaid managed care organizations, including Elevance Health, Centene and UnitedHealth Group, are working with states to secure rates that account for sicker patients.